Clinical Trial Update: EBV-AST Cell Injection for EBV-Associated Lymphoproliferative Disorders [Phase 1, Phase 2]

View source ↗

Summary

The document reports a Phase 1/2 clinical trial evaluating EBV-AST cell injection for Epstein-Barr virus-associated lymphoproliferative disorders and EBV-positi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epstein-barr Virus-associated Lymphoproliferative Disorders
• Epstein-barr Virus-positive Lymphoma

Drugs mentioned

• EBV-AST cell injection

Snippet

Sponsor: Daihong Liu | Conditions: Epstein-Barr Virus-Associated Lymphoproliferative Disorders, EBV-Positive Lymphoma | Phase 1, Phase 2 | Status: RECRUITING